Consequently, these transmitted signals will enhance AP-1 mediated transcription of Clu. The enhancement of insulin signaling has been pursued in AD clinical trials for purported benefits in adult neurogenesis and synaptic function as well. Here, JUN is linked to Alzheimer disease.